It was a challenging time for Ashton and his family and the Cupcakes of Hope organisation reached out, offering aid and support. Cupcakes of Hope is a charity that raises money for children with ...

Opzelura is a treatment for nonsegmental vitiligo in patients 12 and older, making it the first and only cream in the U.S.

A retrospective analysis showed improved overall survival (OS) with Orca-T compared with post-transplant cyclophosphamide in ...

A phase 2 study evaluated the use of ruxolitinib plus standard GVHD prophylaxis in patients with myelofibrosis undergoing ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), a global leader in allogeneic cellular medicines for inflammatory diseases, today ...

Ryoncil ® was approved in December 2024 by the United States Food and Drug Administration (FDA) for steroid-refractory acute ...

We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...

Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the ...

Orca Bio to present efficacy and safety data with Orca-T compared to conventional allogeneic hematopoietic stem cell transplant (alloHSCT) at the 51st Annual ...

Jakafi is approved for use in patients with two types of cancers, myelofibrosis and polycythemia vera. Incyte forecast Jakafi sales in 2025 to be between $2.93 billion and $2.98 billion. Sales of ...

A novel drug regimen tested for the first time by researchers at Fred Hutch Cancer Center has shown great promise in ...